84 related articles for article (PubMed ID: 3890700)
21. Pergolide in the treatment of Parkinson's disease.
Quinn NP; Lang AE; Thompson C; Brincat S; Marsden CD; Parkes JD
Adv Neurol; 1984; 40():509-13. PubMed ID: 6695628
[No Abstract] [Full Text] [Related]
22. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
[TBL] [Abstract][Full Text] [Related]
23. High doses of pergolide improve clinical global impression in advanced Parkinson's disease:- a preliminary open label study.
Arnold G; Gasser T; Storch A; Lipp A; Kupsch A; Hundemer HP; Schwarz J
Arch Gerontol Geriatr; 2005; 41(3):239-53. PubMed ID: 16029905
[TBL] [Abstract][Full Text] [Related]
24. A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease.
Brooks DJ; Abbott RJ; Lees AJ; Martignoni E; Philcox DV; Rascol O; Roos RA; Sagar HJ
Clin Neuropharmacol; 1998; 21(2):101-7. PubMed ID: 9579296
[TBL] [Abstract][Full Text] [Related]
25. Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies.
LeWitt PA; Burns RS; Calne DB
Adv Neurol; 1983; 37():131-40. PubMed ID: 6344586
[TBL] [Abstract][Full Text] [Related]
26. [Clinical study of pergolide in Parkinson's disease].
Gonce M; Delwaide PJ
Presse Med; 1985 Jun; 14(26):1409-11. PubMed ID: 3161045
[TBL] [Abstract][Full Text] [Related]
27. Mesulergine and pergolide in previously untreated Parkinson's disease.
Wright A; Lees AJ; Stern GM
J Neurol Neurosurg Psychiatry; 1987 Apr; 50(4):482-4. PubMed ID: 3585362
[TBL] [Abstract][Full Text] [Related]
28. The use of pergolide, a potent dopamine agonist, in Parkinson's disease.
Lieberman AN; Goldstein M; Neophytides A; Leibowitz M; Gopinathan G; Walker R; Pact V
Clin Pharmacol Ther; 1982 Jul; 32(1):70-5. PubMed ID: 7083733
[TBL] [Abstract][Full Text] [Related]
29. CQP 201-403 in Parkinson's disease: an open-label pilot study.
Pfeiffer RF; Herrera LH; Glaeske CS; Hofman RE
Mov Disord; 1989; 4(3):278-81. PubMed ID: 2571083
[TBL] [Abstract][Full Text] [Related]
30. Mesulergine: a dopamine agonist with novel properties in Parkinson's disease.
Lieberman AN; Gopinathan G; Pasternack P; Goldstein M
Adv Neurol; 1990; 53():533-7. PubMed ID: 1978521
[No Abstract] [Full Text] [Related]
31. Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085.
Schneider E; Hubener K; Fischer PA
Neurology; 1983 Apr; 33(4):468-72. PubMed ID: 6682193
[TBL] [Abstract][Full Text] [Related]
32. CQA 206-291 in Parkinson's disease: an acute single escalating dosage study.
Lang AE; Riley DE; Vachon L; Lataste X
Can J Neurol Sci; 1990 Nov; 17(4):416-9. PubMed ID: 2276100
[TBL] [Abstract][Full Text] [Related]
33. Cabergoline : a review of its use in the treatment of Parkinson's disease.
Curran MP; Perry CM
Drugs; 2004; 64(18):2125-41. PubMed ID: 15341508
[TBL] [Abstract][Full Text] [Related]
34. Three-year observation of mesulergine (CU 32-085) in advanced and newly treated parkinsonism.
Schneider E; Baas H; Fischer PA; Japp G
J Neurol; 1985; 232(1):24-8. PubMed ID: 3998771
[TBL] [Abstract][Full Text] [Related]
35. Effect of ciladopa on Parkinson's disease: a preliminary report.
Weiner WJ; Berger JR
Adv Neurol; 1987; 45():583-6. PubMed ID: 3548268
[No Abstract] [Full Text] [Related]
36. Controlled trial of pergolide mesylate in Parkinson's disease and progressive supranuclear palsy.
Jankovic J
Neurology; 1983 Apr; 33(4):505-7. PubMed ID: 6339985
[TBL] [Abstract][Full Text] [Related]
37. Parkinson's disease: a comparison of mesulergine and bromocriptine.
Burton K; Larsen TA; Robinson RG; Bratty PJ; Martin WR; Schulzer M; Calne DB
Neurology; 1985 Aug; 35(8):1205-8. PubMed ID: 3895033
[TBL] [Abstract][Full Text] [Related]
38. Clinical experience with cabergoline, a new ergoline derivative, in the treatment of Parkinson's disease.
Jori MC; Franceschi M; Giusti MC; Canal N; Piolti R; Frattola L; Bassi S; Calloni E; Mamoli A; Camerlingo M
Adv Neurol; 1990; 53():539-43. PubMed ID: 2239494
[No Abstract] [Full Text] [Related]
39. Long-term experience with pergolide therapy of advanced parkinsonism.
Kurlan R; Miller C; Levy R; Macik B; Hamill R; Shoulson I
Neurology; 1985 May; 35(5):738-42. PubMed ID: 3887213
[TBL] [Abstract][Full Text] [Related]
40. The use of lisuride in severe Parkinson's disease.
Chin D; Yu YL; Huang CY
Clin Exp Neurol; 1986; 22():63-9. PubMed ID: 3581512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
